You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine

Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of Covid vaccine

Topics
Coronavirus Vaccine | Aurobindo Pharma | Coronavirus

Press Trust of India  |  New Delhi 

Coronavirus, vaccine, covid

on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.

has facilitated the establishment of 'the r-VSV vaccine' manufacturing platform for the first time in India by supporting Aurobindo Pharma's COVID-19 vaccine development, the company said in a regulatory filing.

said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.

"Aurobindo is in the process of setting up a state-of-art manufacturing facility for viral vaccineswhich will be used to produce the COVID-19 vaccine and other viral vaccines. The plant will comply with global standards. The company's COVID-19 vaccine development is going as per plan," the filing added.

Commenting on the collaboration, Managing Director N Govindarajan said," It is a matter of immense pride that has placed its trust on our vaccine capabilities. The senior leadership of Aurobindo and Auro Vaccines has extensive experience in development, production and commercialization of several vaccines."

Department of Biotechnology Secretary and Chairperson Renu Swarup said the partnership with Aurobindo is to serve the country's need for a vaccine to fight this pandemic.

"The government is focussed on creating an ecosystem that nurtures and encourages new product innovation to address the most relevant issues to our society," Swarup added.

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the pharma firms in India working on the vaccine.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 15 2020. 17:41 IST
RECOMMENDED FOR YOU
.